Presentation TCT 2018 Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne September 23, 2018
Presentation TCT 2018 US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo September 23, 2018
Presentation TCT 2018 TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation Presenter: Horst Sievert, Brian K. Whisenant, Fabian Nietlispach September 23, 2018
Presentation TCT 2018 Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation Presenter: Philip M. Urban, Robert W. Yeh, C. Michael Gibson September 22, 2018
Presentation TCT 2018 Case Introduction: A Patient With Non-Valvular Atrial Fibrillation Presenter: Martina Kelly Speight, Asma Hussaini, David P. Lee, Elizabeth M. Perpetua September 21, 2018
Presentation TCT 2018 TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation Presenter: Anibal A. Damonte September 21, 2018
Presentation TCT 2018 Atrial Fibrillation and ACS/PCI: The End of Triple Therapy? Presenter: Jeroen J. Bax, Stephan Windecker September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
News Conference News TCT 2017 For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results Yael L. Maxwell November 02, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Four Shelley Wood November 02, 2017
Presentation TCT 2017 PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation Presenter: Saibal Kar November 02, 2017
Presentation TCT 2017 Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Samir R. Kapadia, Ioanna Kosmidou November 01, 2017
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017